-
Barca skipper Raphinha out against Getafe and Galatasaray
-
Djokovic crashes out of Shanghai Masters in his first match
-
MEXC and Payward Highlight Collaboration as Crypto and TradFi Converge at TOKEN2049
-
EU says Turkey's crackdown on rights hampers membership bid
-
EU states agree beefed-up European financial markets watchdog
-
Two Renoir paintings stolen in France recovered: mayor
-
Eritrea, Ethiopia trade barbs as Tigray rebels retreat
-
German leader outraged at Schroeder birthday visit to Putin
-
Kompany 'proud' of Man City success despite guilty verdict
-
Stocks up, oil retreats as Trump rules out pre-vote Iran attack
-
Man City will win appeal over financial charges, says Maresca
-
South African judge Navi Pillay wins Nobel Peace Prize
-
Fernandez logs record lap at Indonesia MotoGP practice
-
'I completely trust the club,' says Man City boss Maresca
-
Navi Pillay: S.Africa's global rights activist and Nobel winner
-
'10 out of 10' Quintana reminisces over dream Vuelta win
-
Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading
-
Maddinson given shock recall but fails to score
-
Russell goes fastest in practice for smoggy Singapore GP
-
Navi Pillay, South African rights champion, wins Nobel Peace Prize
-
For exiled Russian director Zvyagintsev, triumph without belonging
-
Saudi Arabia says three killed at airport as Yemen war expands
-
Home hope Zheng storms into China Open semi-finals
-
Everton's US owners mull sale of club two years after takeover
-
Zverev churns out win in Shanghai Masters opener
-
Ukraine takes Russia fight to 'scorching sands' of Sahel
-
Hurricane Isaias strengthens en route to US Gulf Coast
-
Chinese AI tool pulled to prevent 'misuse' after South Korea hacks
-
US activists deploy poll volunteers over Trump intimidation fears
-
Asian stocks mostly up as traders weigh AI, oil dips after surge
-
Saint Laurent designer Vaccarello leaves after glittering decade
-
Walking through flames: orangutans rescued in Indonesia fires
-
'Tough to stay here': Nepal flood survivors wait for homes
-
LeBron shines in pre-season debut for re-tooled 76ers
-
Malaysia closes schools in capital, parts of country due to haze
-
Okinawa resolution calls for revision of US forces pact after murder
-
Buccaneers stun Cowboys for first win of NFL season
-
Verdict expected Friday in Mexico trial over murders of Australia, US surfers
-
Activists hope trial will stop 'forever chemicals' at Italy plant
-
New York mayor says asking Trump to withdraw ICE after shooting
-
Guardians rally for 9-5 victory over White Sox to stay alive in MLB playoffs
-
Walking through flames: orangutan rescued in Indonesia fires
-
Asian stocks mixed amid AI concerns, oil dips after surge
-
James shines in pre-season debut for re-tooled 76ers
-
Wallabies expect fast-paced All Blacks in Bledisloe opener
-
Fuel, fertilizer costs strain US farmers' support for Republicans in midterms
-
Tech scammer Elizabeth Holmes focus of documentary by absurdist Nathan Fielder
-
Trump's 'super intelligence' rebrand to sell AI faces uphill battle
-
Climate hopes shift from politics to the courts
-
Fiji demands US provide evidence Chinese official paid bribes for Beijing
US surgeons report longest successful pig-to-human kidney transplant
US surgeons who transplanted a genetically modified pig kidney into a brain-dead patient announced Thursday they had ended their experiment after a record-breaking 61 days.
The latest experimental procedure is part of a growing field of research aimed at advancing cross-species transplants, mainly testing the technique on bodies that have been donated for science.
There are more than 103,000 people waiting for organ transplants in the United States, 88,000 of whom need kidneys.
"We have learned a great deal throughout these past two months of close observation and analysis, and there is great reason to be hopeful for the future," said Robert Montgomery, director of the New York University Langone Transplant Institute, who led the surgery in July.
It was the the fifth so-called xenotransplant performed by Montgomery, who also carried out the world's first genetically modified pig kidney transplant in September 2021.
Tissue collected during the study indicated a mild rejection process had begun, requiring intensification of immunosuppression medication.
By "knocking out" the gene responsible for a biomolecule called alpha-gal -- a prime target for roving human antibodies -- the NYU Langone team were able to stop immediate rejection.
The donor pig in this experiment came from a herd cultivated by Virginia-based biotech company Revivicor.
The herd has also been approved by the Food and Drug Administration as a source of meat for people with hypersensitivity to the alpha-gal molecule, an allergy caused by some tick bites.
These pigs are bred, not cloned, meaning the process can be more easily scaled.
Early xenotransplantation research focused on harvesting organs from primates -- for example, a baboon heart was transplanted into a newborn known as "Baby Fae" in 1984, but she survived only 20 days.
Current efforts focus on pigs, which are thought to be ideal donors for humans because of their organ size, their rapid growth and large litters, and the fact they are already raised as a food source.
In January 2022, surgeons at the University of Maryland Medical School carried out the world's first pig-to-human transplant on a living patient -- this time involving a heart.
He died two months after the milestone, with the presence of porcine cytomegalovirus in the organ later blamed.
Last week, Chinese scientists published a paper showing they had succeeded in hybrid pig-human kidneys in pig embryos, an alternative approach that also has the potential to one day help address organ donation shortages.
But the development raised ethical issues -- especially since some human cells were also found in the pigs' brains, experts said.
E.Aziz--SF-PST